
The omicron variant, which may well be now circulating in India given the sharp increase in positivity rates in many parts of the country, has shaken up the government’s approach to the vaccination programme. The government has announced that a booster dose would become available to sections of the population, and gave emergency use authorisations for two new vaccines and an antiviral pill. In this context, our lead editorial notes that the government must also ensure that it makes advance purchases on the right scale. There is now a real chance to accelerate the completion of India’s vaccination programme and also open up the booster dose to all adults. Read here
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Already a premium subscriber? LOGIN NOW
What you get on Business Standard Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
-
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
-
26 years of website archives.
-
Preferential invites to Business Standard events.

Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.
Download the Business Standard App for latest Business News and Market News .
First Published: Fri, December 31 2021. 06:30 IST
RECOMMENDED FOR YOU